Abbott Laboratories (BUE:ABT) Cyclically Adjusted Book per Share: ARS9,577.25 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:ABT Abbott Laboratories BUE:ABT
67 GF Score
Price ARS41,260.00
GF Value ARS51,968.09
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott Laboratories Cyclically Adjusted Book per Share?

Abbott Laboratories BUE:ABT -3.42% 67 Cyclically Adjusted Book per Share is ARS9,577.25 as of Jun. 2026. GuruFocus rates BUE:ABT with a GF Score™ of 67/100 and a GF Value™ of ARS51,968.09 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Abbott Laboratories's adjusted book value per share for the three months ended in Jun. 2026 was ARS87,499.984. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS9,577.25 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Abbott Laboratories's average Cyclically Adjusted Book Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Abbott Laboratories was 14.20% per year. The lowest was 3.30% per year. And the median was 8.60% per year.

As of today (2026-07-31), Abbott Laboratories's current stock price is ARS41260.00. Abbott Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ARS9,577.25. Abbott Laboratories's Cyclically Adjusted PB Ratio of today is 4.31.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abbott Laboratories was 7.55. The lowest was 2.54. And the median was 5.11.


Abbott Laboratories  (BUE:ABT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Abbott Laboratories's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=41260.00/9577.25
=4.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Abbott Laboratories was 7.55. The lowest was 2.54. And the median was 5.11.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Abbott Laboratories Cyclically Adjusted Book per Share Related Terms


Abbott Laboratories Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Cyclically Adjusted Book per Share Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 949.66 1,691.66 5,044.04 6,459.13 8,870.32

Abbott Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,881.93 8,905.32 8,870.32 8,793.35 9,577.25

BUE:ABT vs SYK, MDT, BSX: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PB Ratio falls into.


BUE:ABT
67GF Score
Abbott Laboratories BUE:ABT
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=87499.984/333.9520*333.9520
=87,499.984

Current CPI (Jun. 2026) = 333.9520.

Abbott Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201609 420.985 241.428 582.322
201612 442.101 241.432 611.520
201703 557.271 243.801 763.335
201706 599.793 244.955 817.710
201709 644.965 246.819 872.653
201712 676.735 246.524 916.734
201803 721.723 249.554 965.806
201806 869.386 251.989 1,152.166
201809 1,286.672 252.439 1,702.141
201812 1,311.112 251.233 1,742.798
201903 1,370.446 254.202 1,800.392
201906 1,602.015 256.143 2,088.662
201909 2,012.374 256.759 2,617.382
201912 2,108.638 256.974 2,740.292
202003 2,120.716 258.115 2,743.805
202006 2,364.682 257.797 3,063.225
202009 2,629.369 260.280 3,373.609
202012 3,012.553 260.474 3,862.374
202103 3,403.007 264.877 4,290.448
202106 3,612.186 271.696 4,439.877
202109 3,806.831 274.310 4,634.533
202112 4,099.179 278.802 4,910.040
202203 4,341.507 287.504 5,042.904
202206 5,014.609 296.311 5,651.625
202209 5,686.069 296.808 6,397.651
202212 7,078.400 296.797 7,964.521
202303 8,408.916 301.836 9,303.643
202306 10,282.328 305.109 11,254.352
202309 15,110.643 307.789 16,395.094
202312 16,072.748 306.746 17,498.277
202403 37,591.155 312.332 40,193.260
202406 40,472.796 314.175 43,020.518
202409 43,617.245 315.301 46,197.336
202412 55,599.349 315.605 58,831.494
202503 59,815.142 319.799 62,462.316
202506 68,984.575 322.561 71,420.714
202509 79,587.415 324.800 81,829.977
202512 87,142.832 324.054 89,804.548
202603 83,584.169 330.213 84,530.592
202606 87,499.984 333.952 87,499.984

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ARS9,577.25 mean?
Abbott Laboratories (BUE:ABT) has a Cyclically Adjusted Book per Share of ARS9,577.25 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Cyclically Adjusted Book per Share too high?
Abbott Laboratories' current Cyclically Adjusted Book per Share is ARS9,577.25. Overall, Abbott Laboratories has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Cyclically Adjusted Book per Share compare to SYK and MDT?
Abbott Laboratories' Cyclically Adjusted Book per Share of ARS9,577.25 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Cyclically Adjusted Book per Share is ARS9,577.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (BUE:ABT) is currently considered Modestly Undervalued. The stock's GF Value™ is ARS51,968.09, compared to a current price of ARS41,260.00 — trading 20.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is ARS9,577.25. Abbott Laboratories' overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Abbott Laboratories (BUE:ABT), the current Cyclically Adjusted Book per Share is ARS9,577.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (BUE:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of ARS41,260.00 is trading 20.6% below its estimated GF Value™ of ARS51,968.09. GuruFocus considers Abbott Laboratories to be Modestly Undervalued.

Key valuation signals for BUE:ABT:

  • Cyclically Adjusted Book per Share: ARS9,577.25
  • GF Value™: ARS51,968.09 vs. price of ARS41,260.00 (20.6% below fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the BUE:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
67GF Score

Get the complete analysis for BUE:ABT

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS41,260.00
Price
ARS51,968.09
GF Value